Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) just unveiled an announcement.
4DMedical Limited has applied to the ASX for quotation of a new batch of fully paid ordinary shares issued following the exercise of options or conversion of other convertible securities. The securities, which were issued on 30 December 2025, represent a routine capital markets event that modestly increases the company’s quoted share base and may provide additional liquidity for investors without indicating a change in strategic direction.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited (ASX: 4DX) is an Australian-listed company operating in the medical technology sector, focused on imaging-based respiratory diagnostics. The company develops and commercialises software and related technologies that analyse lung function, targeting healthcare providers and institutions involved in respiratory care and pulmonary medicine.
Average Trading Volume: 4,835,469
Technical Sentiment Signal: Buy
Current Market Cap: A$1.96B
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.